From the Desk of Steve Strazza and Alfonso Depablos
The most significant insider buy on today’s list comes via a Form 4 filing by ProKidney Corp $PROK director Pablo G. Legorreta.
Legorreta acquired 22,617,909 PROK shares, equivalent to $54 million.